Insmed
INSM
#542
Rank
C$60.73 B
Marketcap
C$284.78
Share price
-0.51%
Change (1 day)
169.61%
Change (1 year)

Insmed (INSM) Fails to deliver data

Key failure to deliver metrics for Insmed:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Insmed (INSM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Insmed (INSM) - since 2013

Volume in USD (price x number of shares), data since 2013

Insmed (INSM) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025C$54.73 M36.9%
2024C$39.98 M264.99%
2023C$10.95 M15.72%
2022C$9.46 M-28.5%
2021C$13.23 M29.75%
2020C$10.2 M-74.29%
2019C$39.68 M48.24%
2018C$26.76 M204.1%
2017C$8.8 M123.23%
2016C$3.94 M-32.13%
2015C$5.8 M-38.86%
2014C$9.5 M211.03%
2013C$3.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Sarepta Therapeutics
SRPT
C$2.3 MC$22.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$18.77 MC$0.12 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
C$60.15 MC$0.26 B๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
C$24.43 MC$43.45 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/AC$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$42.51 MC$96.84 M๐Ÿ‡บ๐Ÿ‡ธ USA